These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6289301)

  • 1. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
    Neuwelt EA; Barnett PA; Bigner DD; Frenkel EP
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4420-3. PubMed ID: 6289301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery.
    Neuwelt EA; Barnett PA; Frenkel EP
    Neurosurgery; 1984 Feb; 14(2):154-60. PubMed ID: 6200798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
    Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
    Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
    Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
    No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry.
    Adam JF; Biston MC; Joubert A; Charvet AM; Le Bas JF; Estève F; Elleaume H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1173-82. PubMed ID: 15752899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
    Neuwelt EA; Diehl JT; Vu LH; Hill SA; Michael AJ; Frenkel EP
    Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
    Neuwelt EA; Maravilla KR; Frenkel EP; Rapaport SI; Hill SA; Barnett PA
    J Clin Invest; 1979 Aug; 64(2):684-8. PubMed ID: 457877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
    Dean RL; Emerich DF; Hasler BP; Bartus RT
    Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
    Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
    Ohno K; Fredericks WR; Rapoport SI
    Surg Neurol; 1979 Oct; 12(4):323-8. PubMed ID: 524251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.
    Neuwelt EA; Howieson J; Frenkel EP; Specht HD; Weigel R; Buchan CG; Hill SA
    Neurosurgery; 1986 Oct; 19(4):573-82. PubMed ID: 3097567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.
    Neuwelt EA; Frenkel EP; Rapoport S; Barnett P
    Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
    Cosolo W; Christophidis N
    Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas.
    Warnke PC; Blasberg RG; Groothuis DR
    Ann Neurol; 1987 Sep; 22(3):300-5. PubMed ID: 3118762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.
    Neuwelt EA; Hill SA; Frenkel EP
    Neurosurgery; 1984 Sep; 15(3):362-6. PubMed ID: 6090973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of steroids on gentamicin delivery to brain after blood-brain barrier disruption.
    Neuwelt EA; Horaczek A; Pagel MA
    J Neurosurg; 1990 Jan; 72(1):123-6. PubMed ID: 2294171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
    Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.